CRISPR/Cas9-mediated genome editing of Epstein–Barr virus in human cells

Journal of General Virology

Volumn 96, Issue 3, 2015, Pages 626-636

  Yuen, Kit San ^a   Chan, Chi Ping ^a   Wong, Nok Hei Mickey ^a   Ho, Chau Ha ^a   Ho, Ting Hin ^a   Lei, Ting ^b   Deng, Wen ^a   Tsao, Sai Wah ^a   Chen, Honglin ^a   Kok, Kin Hang ^a   Jin, Dong Yan ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOMA CELL; CELL SELECTION; CONTROLLED STUDY; CRISPR CAS SYSTEM; EPITHELIUM CELL; EPSTEIN BARR VIRUS; GENETIC PROCEDURES; GENETIC TRANSFECTION; GENOME EDITING; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS RECOMBINANT; CLASSIFICATION; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETIC REASSORTMENT; GENETICS; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY; RNA EDITING;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

CRISPR ASSOCIATED PROTEIN; GENETIC MARKER; VIRUS PROTEIN; VIRUS RNA;

CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-ASSOCIATED PROTEINS; GENE EXPRESSION REGULATION, VIRAL; GENETIC MARKERS; HEK293 CELLS; HERPESVIRUS 4, HUMAN; HUMANS; REASSORTANT VIRUSES; RNA EDITING; RNA, VIRAL; VIRAL PROTEINS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 84923672936     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/jgv.0.000012     Document Type: Article

References (47)

1. Adams, A. & Lindahl, T. (1975). Epstein–Barr virus genomes with properties of circular DNA molecules in carrier cells. Proc Natl Acad Sci U S A 72, 1477–1481.
2. Bi, Y., Sun, L., Gao, D., Ding, C., Li, Z., Li, Y., Cun, W. & Li, Q. (2014). High-efficiency targeted editing of large viral genomes by RNAguided nucleases. PLoS Pathog 10, e1004090.
3. Böttcher, R., Hollmann, M., Merk, K., Nitschko, V., Obermaier, C., Philippou-Massier, J., Wieland, I., Gaul, U. & Förstemann, K. (2014). Efficient chromosomal gene modification with CRISPR/cas9 and PCRbased homologous recombination donors in cultured Drosophila cells. Nucleic Acids Res 42, e89.
4. Cai, X., Schäfer, A., Lu, S., Bilello, J. P., Desrosiers, R. C., Edwards, R., Raab-Traub, N. & Cullen, B. R. (2006). Epstein–Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2, e23.
5. Chen, H., Hutt-Fletcher, L., Cao, L. & Hayward, S. D. (2003). A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein–Barr virus. J Virol 77, 4139–4148.
6. Chen, A., Divisconte, M., Jiang, X., Quink, C. & Wang, F. (2005a). Epstein–Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro. J Virol 79, 4506–4509.
7. Chen, H., Huang, J., Wu, F. Y., Liao, G., Hutt-Fletcher, L. & Hayward, S. D. (2005b). Regulation of expression of the Epstein–Barr virus BamHI-A rightward transcripts. J Virol 79, 1724–1733.
8. Cheung, S. T., Huang, D. P., Hui, A. B., Lo, K. W., Ko, C. W., Tsang, Y. S., Wong, N., Whitney, B. M. & Lee, J. C. (1999). Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein–Barr virus. Int J Cancer 83, 121–126.
9. Cho, S. W., Kim, S., Kim, Y., Kweon, J., Kim, H. S., Bae, S. & Kim, J. S. (2014). Analysis of off-target effects of CRISPR/Cas-derived RNAguided endonucleases and nickases. Genome Res 24, 132–141.
10. Choy, E. Y. W., Kok, K. H., Tsao, S. W. & Jin, D. Y. (2008a). Utility of Epstein–Barr virus-encoded small RNA promoters for driving the expression of fusion transcripts harboring short hairpin RNAs. Gene Ther 15, 191–202.
11. Choy, E. Y. W., Siu, K. L., Kok, K. H., Lung, R. W. M., Tsang, C. M., To, K. F., Kwong, D. L., Tsao, S. W. & Jin, D. Y. (2008b). An Epstein–Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med 205, 2551–2560.
12. Edwards, R. H., Marquitz, A. R. & Raab-Traub, N. (2008). Epstein Barr virus BART microRNAs are produced from a large intron prior to splicing. J Virol 82, 9094–9106.
13. Feederle, R., Bartlett, E. J. & Delecluse, H. J. (2010). Epstein–Barr virus genetics: talking about the BAC generation. Herpesviridae 1, 6.
14. Feederle, R., Linnstaedt, S. D., Bannert, H., Lips, H., Bencun, M., Cullen, B. R. & Delecluse, H. J. (2011). A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus. PLoS Pathog 7, e1001294.
15. Geiser, V., Cahir-McFarland, E. & Kieff, E. (2011). Latent membrane protein 1 is dispensable for Epstein–Barr virus replication in human embryonic kidney 293 cells. PLoS One 6, e22929.
16. Hsu, P. D., Lander, E. S. & Zhang, F. (2014). Development and applications of CRISPR-Cas9 for genome engineering. Cell 157, 1262–1278.
17. Kanda, T., Yajima, M., Ahsan, N., Tanaka, M. & Takada, K. (2004). Production of high-titer Epstein–Barr virus recombinants derived from Akata cells by using a bacterial artificial chromosome system. J Virol 78, 7004–7015.
18. Kew, C., Lui, P. Y., Chan, C. P., Liu, X., Au, S. W. N., Mohr, I., Jin, D. Y. & Kok, K. H. (2013). Suppression of PACT-induced type I interferon production by herpes simplex virus 1 Us11 protein. J Virol 87, 13141–13149.
19. Kwok, H., Wu, C. W., Palser, A. L., Kellam, P., Sham, P. C., Kwong, D. L. W. & Chiang, A. K. S. (2014). Genomic diversity of Epstein–Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples. J Virol 88, 10662–10672.
20. Lan, K., Verma, S. C., Murakami, M., Bajaj, B. & Robertson, E. S. (2007). Epstein–Barr Virus (EBV): infection, propagation, quantitation, and storage. Curr Protoc Microbiol Chapter 14, 2.
21. Lei, T., Yuen, K. S., Tsao, S. W., Chen, H., Kok, K. H. & Jin, D. Y. (2013a). Perturbation of biogenesis and targeting of Epstein–Barr virus-encoded miR-BART3 microRNA by adenosine-to-inosine editing. J Gen Virol 94, 2739–2744.
22. Lei, T., Yuen, K. S., Xu, R., Tsao, S. W., Chen, H., Li, M., Kok, K. H. & Jin, D. Y. (2013b). Targeting of DICE1 tumor suppressor by Epstein Barr virus-encoded miR-BART3 microRNA in nasopharyngeal carcinoma. Int J Cancer 133, 79–87.
23. Lieberman, P. M. (2013). Keeping it quiet: chromatin control of gamm herpesvirus latency. Nat Rev Microbiol 11, 863–875.
24. Lin, Z., Wang, X., Strong, M. J., Concha, M., Baddoo, M., Xu, G., Baribault, C., Fewell, C., Hulme, W. & other authors (2013). Wholegenome sequencing of the Akata and Mutu Epstein–Barr virus strains. J Virol 87, 1172–1182.
25. Liu, P. & Speck, S. H. (2003). Synergistic autoactivation of the Epstein–Barr virus immediate-early BRLF1 promoter by Rta and Zta. Virology 310, 199–206.
26. Liu, P., Fang, X., Feng, Z., Guo, Y. M., Peng, R. J., Liu, T., Huang, Z., Feng, Y., Sun, X. & other authors (2011). Direct sequencing and characterization of a clinical isolate of Epstein–Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology. J Virol 85, 11291–11299.
27. Lo, A. K. F., Dawson, C. W., Jin, D. Y. & Lo, K. W. (2012). The pathological roles of BART miRNAs in nasopharyngeal carcinoma. J Pathol 227, 392–403.
28. Lun, S. W. M., Cheung, S. T., Cheung, P. F. Y., To, K. F., Woo, J. K. S., Choy, K. W., Chow, C., Cheung, C. C. M., Chung, G. T. Y. & other authors (2012). CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma. PLoS ONE 7, e52426.
29. Mali, P., Esvelt, K. M. & Church, G. M. (2013). Cas9 as a versatile tool for engineering biology. Nat Methods 10, 957–963.
30. Marquitz, A. R., Mathur, A., Chugh, P. E., Dittmer, D. P. & Raab-Traub, N. (2014). Expression profile of microRNAs in Epstein–Barr virusinfected AGS gastric carcinoma cells. J Virol 88, 1389–1393.
31. Raab-Traub, N. (2012). Novel mechanisms of EBV-induced oncogenesis. Curr Opin Virol 2, 453–458.
32. Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A. & Zhang, F. (2013). Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8, 2281–2308.
33. Riley, K. J., Rabinowitz, G. S., Yario, T. A., Luna, J. M., Darnell, R. B. & Steitz, J. A. (2012). EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J 31, 2207–2221.
34. Sarisky, R. T. & Hayward, G. S. (1996). Evidence that the UL84 gene product of human cytomegalovirus is essential for promoting oriLytdependent DNA replication and formation of replication compartments in cotransfection assays. J Virol 70, 7398–7413.
35. Seto, E., Moosmann, A., Grömminger, S., Walz, N., Grundhoff, A. & Hammerschmidt, W. (2010). Micro RNAs of Epstein–Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathog 6, e1001063.
36. Shen, B., Zhang, W., Zhang, J., Zhou, J., Wang, J., Chen, L., Wang, L., Hodgkins, A., Iyer, V. & other authors (2014). Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects. Nat Methods 11, 399–402.
37. Shimizu, N., Yoshiyama, H. & Takada, K. (1996). Clonal propagation of Epstein–Barr virus (EBV) recombinants in EBV-negative Akata cells. J Virol 70, 7260–7263.
38. Siu, K. L., Yeung, M. L., Kok, K. H., Yuen, K. S., Kew, C., Lui, P. Y., Chan, C. P., Tse, H., Woo, P. C. Y. & other authors (2014). Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIGI and MDA5 in the innate antiviral response. J Virol 88, 4866–4876.
39. Tang, H. M. V., Gao, W. W., Chan, C. P., Siu, Y. T., Wong, C. M., Kok, K. H., Ching, Y. P., Takemori, H. & Jin, D. Y. (2013). LKB1 tumor suppressor and salt-inducible kinases negatively regulate human Tcell leukemia virus type 1 transcription. Retrovirology 10, 40.
40. Terns, R. M. & Terns, M. P. (2014). CRISPR-based technologies: prokaryotic defense weapons repurposed. Trends Genet 30, 111–118.
41. Tsai, M. H., Raykova, A., Klinke, O., Bernhardt, K., Ga¨ rtner, K., Leung, C. S., Geletneky, K., Sertel, S., Mu¨ nz, C. & other authors (2013). Spontaneous lytic replication and epitheliotropism define an Epstein Barr virus strain found in carcinomas. Cell Rep 5, 458–470.
42. Tsang, C. M., Zhang, G., Seto, E., Takada, K., Deng, W., Yip, Y. L., Man, C., Hau, P. M., Chen, H. & other authors (2010). Epstein–Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization. Int J Cancer 127, 1570–1583.
43. Tsang, C. M., Yip, Y. L., Lo, K. W., Deng, W., To, K. F., Hau, P. M., Lau, V. M., Takada, K., Lui, V. W. & other authors (2012). Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells. Proc Natl Acad Sci U S A 109, E3473–E3482.
44. Tso, K. K., Yip, K. Y., Mak, C. K., Chung, G. T., Lee, S. D., Cheung, S. T., To, K. F. & Lo, K. W. (2013). Complete genomic sequence of Epstein Barr virus in nasopharyngeal carcinoma cell line C666-1. Infect Agent Cancer 8, 29.
45. Umbach, J. L. & Cullen, B. R. (2009). The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev 23, 1151–1164.
46. Westphal, E. M., Sierakowska, H., Livanos, E., Kole, R. & Vos, J. M. (1998). A system for shuttling 200-kb BAC/PAC clones into human cells: stable extrachromosomal persistence and long-term ectopic gene activation. Hum Gene Ther 9, 1863–1873.
47. Yip, Y. L., Pang, P. S., Deng, W., Tsang, C. M., Zeng, M., Hau, P. M., Man, C., Jin, Y., Yuen, A. P. & Tsao, S. W. (2013). Efficient immortalization of primary nasopharyngeal epithelial cells for EBV infection study. PLoS One 8, e78395.